Melanoma diagnosis during COVID-19: delay, disruption and the question of overdiagnosis.

Publication date: Jun 07, 2026

Concepts Keywords
Clinical Clinical
Covid Covid
Dermatol Delay
Overdiagnosis Dermatol
Diagnosis
Disruption
Melanoma
Overdiagnosis
Question

Semantics

Type Source Name
disease MESH Melanoma
pathway KEGG Melanoma
disease MESH COVID-19
drug DRUGBANK Bismuth subgallate

Original Article

(Visited 15 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *